Evidence map›Paper›PMID 30846830›Full record

ArticleMucosal immunology2019

The human lung mucosa drives differential Mycobacterium tuberculosis infection outcome in the alveolar epithelium.

J M Scordo, A M Olmo-Fontánez, H V Kelley, S Sidiki, J Arcos, A Akhter, M D Wewers, J B Torrelles

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Genes required forbioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Article
  4. Drug resistantbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Exposure ofFrontiers in tuberculosis · 2024
    Article
  7. Review
  8. Challenges in Developing a Controlled Human Tuberculosis Challenge Model.Current topics in microbiology and immunology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Early innate cell interactions withFrontiers in immunology · 2023
    Review
  14. Review
  15. Article
  16. Host- and Age-Dependent Transcriptional Changes inInternational journal of molecular sciences · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

J M ScordoDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
A M Olmo-FontánezTexas Biomedical Research Institute, San Antonio, TX, 78229, USA.
H V KelleyDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
S SidikiDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
J ArcosDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
A AkhterTexas Biomedical Research Institute, San Antonio, TX, 78229, USA.
M D WewersDepartment of Internal Medicine, Pulmonary, Critical Care and Sleep Medicine Division, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
J B TorrellesDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA. jtorrelles@txbiomed.org.
The Ohio State University · USTexas Biomedical Research Institute · USInterface (United States) · US

Funding

Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Function of human lung mucosal hydrolases during M. tuberculosis infectionR01AI093570 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2012 to 2015
$1.6M
Interdisciplinary Program in Microbe-Host BiologyT32AI112542 · NIAID · OHIO STATE UNIVERSITY · PI JUSTICE, SHERYL S, WOZNIAK, DANIEL J · 2014 to 2018
$644k
Remodeling of the M. tuberculosis cell wall by the host microenvironmentR00AI073856 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2009 to 2010
$561k
Remodeling of the M. tuberculosis cell wall by the host microenvironmentK99AI073856 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2008 to 2008
$90k
NIAID NIH HHS K99 AI073856NIAID NIH HHS R00 AI073856NIAID NIH HHS R01 AI093570NIAID NIH HHS T32 AI112542NIGMS NIH HHS T32 GM068412
6 · The paper itself

Abstract

Mycobacterium tuberculosis (M.tb) is deposited into the alveolus where it first encounters the alveolar lining fluid (ALF) prior contacts host cells. We demonstrated that M.tb-exposure to human ALF alters its cell surface, driving better M.tb infection control by professional phagocytes. Contrary to these findings, our results with non-professional phagocytes alveolar epithelial cells (ATs) define two distinct subsets of human ALFs; where M.tb exposure to Low (L)-ALF or High(H)-ALF results in low or high intracellular bacterial growth rates in ATs, respectively. H-ALF exposed-M.tb growth within ATs was independent of M.tb-uptake, M.tb-trafficking, and M.tb-infection induced cytotoxicity; however, it was associated with enhanced bacterial replication within LAMP-1

Indexed as

A549 CellsApoptosisCell AdhesionCytotoxicity, ImmunologicDNA, BacterialDNA ReplicationEpithelial CellsHumansImmunity, InnateLungMycobacterium tuberculosisPhagocytosisPulmonary AlveoliRespiratory MucosaTuberculosis, PulmonaryDNA, Bacterial

Identifiers

PMID30846830
PMCPMC6462240
OpenAlexW2919874306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.